Prevalence of Obesity 40.3 Percent in U.S. From August 2021 to August 2023
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Sept. 24, 2024 -- The prevalence of obesity among adults was 40.3 percent during August 2021 to August 2023, according to a September data brief published by the National Center for Health Statistics.
Samuel D. Emmerich, D.V.M., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues used data from the National Health and Nutrition Examination Survey to examine prevalence estimates of adult obesity and severe obesity during August 2021 to August 2023 by age and sex.
The researchers found that the prevalence of obesity was 40.3 percent in adults during August 2021 to August 2023, with no significant differences seen between men and women. A higher prevalence of obesity was seen for adults ages 40 to 59 years than for those aged 20 to 39 years and 60 years and older. Adults with a bachelor's degree or higher had a lower prevalence of obesity than those with less education. The prevalence of severe obesity was 9.4 percent; in each age group, prevalence was higher for women than men. The age-adjusted prevalence of obesity did not change from 2013-2014 through August 2021-August 2023, while the prevalence of severe obesity increased from 7.7 to 9.7 percent.
"In the United States, the prevalence of obesity in adults remains above the Healthy People 2030 goal of 36.0 percent, but from 2013-2014 through August 2021-August 2023, the age-adjusted prevalence of obesity in adults did not change significantly," the authors write. "Monitoring obesity prevalence is important for understanding trends over time."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-09-25 12:00
Read more
- Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer
- ASA: Risk for Postoperative Delirium Increased With Poor and Worsening Sleep
- First Patient Dosed in Clinical Trial of ABI-110, a Groundbreaking Gene Therapy for Wet AMD Including PCV
- Higher Physical Activity Levels Can Increase Life Expectancy
- Dementia Death Rates in U.S. Older Adults Fluctuated From 2018 to 2022
- AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designations for AB-1003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions